ophthalmology

https://pharmaphorum.com/partner-content/nicox-discusses-new-glaucoma-treatment-at-smis-3rd-ophthalmic-drugs-conference/

Could Kyowa Kirin be eyeing ophthalmology use for cancer drug tivozanib?

https://pharmaphorum.com/news/could-kyowa-kirin-be-eyeing-ophthalmology-use-for-cancer-drug-tivozanib/

Oxford Biomedica signs ophthalmology R&D deal with Santen

https://pharmaphorum.com/news/oxford-biomedica-signs-ophthalmology-rd-deal-with-santen/

Bayer begins phase 3 trial testing aflibercept in infant blindness

https://pharmaphorum.com/news/bayer-begins-phase-3-trial-testing-aflibercept-in-infant-blindness/

Registration opens for SMi’s 3rd Annual Ophthalmic Drugs Conference

https://pharmaphorum.com/partner-content/registration-opens-for-smis-3rd-annual-ophthalmic-drugs-conference/

NICE backs Alimera’s three-year uveitis implant

https://pharmaphorum.com/news/nice-backs-alimeras-three-year-uveitis-implant/

Ophthalmic Drugs Conference

https://pharmaphorum.com/events/ophthalmic-drugs-conference/

Novartis shows off pipeline – including 25 potential blockbusters

https://pharmaphorum.com/news/novartis-shows-off-pipeline-including-25-potential-blockbusters/

Ping An completes trial of AI-based retinal disease screening system

https://pharmaphorum.com/news/ping-an-completes-trial-of-ai-based-retinal-disease-screening-system/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search